Brief: Magenta Therapeutics And Dianthus Therapeutics Announce Merger Agreement

Dianthus Therapeutics

03/05/2023 12:20

Magenta Therapeutics Inc  MGTA.O :
    * MAGENTA THERAPEUTICS AND DIANTHUS THERAPEUTICS ANNOUNCE
MERGER
AGREEMENT
    * MAGENTA THERAPEUTICS - COMBINED CO EXPECTED TO HAVE
APPROXIMATELY $180 MILLION OF CASH OR CASH EQUIVALENTS AT DEAL
CLOSE
    * MAGENTA - CASH TO FUND LEAD PROGRAM DNTH103 THROUGH
CLINICAL
DATA CATALYSTS, PHASE 2 TRIALS IN GENERALIZED MYASTHENIA GRAVIS,
OTHER INDICATIONS
    * MAGENTA THERAPEUTICS - DIANTHUS SECURED COMMITMENTS FOR
$70
MILLION PRIVATE INVESTMENT IN COMMON STOCK AND PRE-FUNDED
WARRANTS
    * MAGENTA - COMBINED CO TO OPERATE UNDER NAME DIANTHUS
THERAPEUTICS INC & TRADE ON NASDAQ UNDER TICKER "DNTH"

Source text for Eikon:  ID:nGNX3LWl59 
Further company coverage:  MGTA.O